David Ian Johnson Insider Trading $ALQA Adynxx, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for David Ian Johnson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David Ian Johnson. David Ian Johnson is CEO and Chairman in Enveric Biosciences, Inc. ($SPAZ.OB) and Director in Alliqua BioMedical, Inc. ($ALQA) and President and CEO in Alliqua BioMedical, Inc. ($ALQA).
David Ian Johnson in Adynxx, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of David Ian Johnson: President and CEO, Director
Holdings: 1,994,535 shares
Current Value: $1,096,994
Latest Transaction: Jun 29 2017
$ALQA Market Capitalization: $17.78M
$ALQA Previous Close: $0.55
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of David Ian Johnson in Adynxx, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 29 2017 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Grant | A | 0.00 | 300,000 | 0 | 1,994,535 | 1.7 M to 2 M (+17.70 %) |
| Jun 26 2017 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Grant | A | 0.00 | 500,000 | 0 | 1,694,535 | 1.2 M to 1.7 M (+41.86 %) |
| Apr 04 2017 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Buy | P | 0.40 | 250,000 | 100,000 | 1,194,535 | 944.5 K to 1.2 M (+26.47 %) |
| May 13 2016 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Grant | A | 0.00 | 300,000 | 0 | 944,535 | 644.5 K to 944.5 K (+46.55 %) |
| Feb 11 2016 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Grant | A | 0.00 | 59,932 | 0 | 644,535 | 584.6 K to 644.5 K (+10.25 %) |
| Nov 09 2015 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Buy | P | 2.92 | 8,650 | 25,258 | 584,603 | 576 K to 584.6 K (+1.50 %) |
| Jul 06 2015 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Payment of Exercise | F | 5.35 | 19,191 | 102,672 | 575,953 | 595.1 K to 576 K (-3.22 %) |
| May 28 2015 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Buy | P | 4.65 | 10,000 | 46,458 | 595,144 | 585.1 K to 595.1 K (+1.71 %) |
| Apr 03 2015 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Payment of Exercise | F | 5.19 | 20,590 | 106,862 | 585,144 | 605.7 K to 585.1 K (-3.40 %) |
| Mar 10 2015 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Payment of Exercise | F | 5.29 | 7,673 | 40,590 | 605,734 | 613.4 K to 605.7 K (-1.25 %) |
| Jul 02 2013 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Option Exercise | A | 0.10 | 617,284 | 59,877 | 617,284 | |
| Jul 02 2013 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Buy | P | 0.00 | 617,284 | 0 | 1,234,568 | 617.3 K to 1.2 M (+100.00 %) |
| Feb 25 2013 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Option Exercise | A | 0.10 | 617,284 | 59,877 | 617,284 | |
| Feb 25 2013 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Buy | P | 0.00 | 617,284 | 0 | 617,284 | 0 to 617.3 K |
| Feb 25 2013 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Option Exercise | A | 0.08 | 12,216,195 | 916,215 | 12,216,195 | |
| Dec 03 2012 | ALQA | Alliqua BioMedical ... | Johnson David Ian | Director | Option Exercise | A | 0.20 | 2,590,000 | 518,000 | 2,590,000 | |
| Dec 03 2012 | ALQA | Alliqua BioMedical ... | Johnson David Ian | Director | Option Exercise | A | 0.15 | 2,590,000 | 388,500 | 2,590,000 | |
| Dec 03 2012 | ALQA | Alliqua BioMedical ... | Johnson David Ian | Director | Option Exercise | A | 0.10 | 2,590,000 | 259,000 | 2,590,000 |
Page: 1